×







We sell 100% Genuine & New Books only!

Duchenne Muscular Dystrophy Advances In Therapeutics at Meripustak

Duchenne Muscular Dystrophy Advances In Therapeutics by Jeffrey S. Chamberlain , Thomas A. Rando, Taylor & Francis

Books from same Author: Jeffrey S. Chamberlain , Thomas A. Rando

Books from same Publisher: Taylor & Francis

Related Category: Author List / Publisher List


  • Price: ₹ 19268.00/- [ 21.00% off ]

    Seller Price: ₹ 15221.00

Estimated Delivery Time : 4-5 Business Days

Sold By: Meripustak      Click for Bulk Order

Free Shipping (for orders above ₹ 499) *T&C apply.

In Stock

We deliver across all postal codes in India

Orders Outside India


Add To Cart


Outside India Order Estimated Delivery Time
7-10 Business Days


  • We Deliver Across 100+ Countries

  • MeriPustak’s Books are 100% New & Original
  • General Information  
    Author(s) Jeffrey S. Chamberlain , Thomas A. Rando
    PublisherTaylor & Francis
    ISBN9780824723255
    Pages496
    BindingHardback
    LanguageEnglish
    Publish YearApril 2006

    Description

    Taylor & Francis Duchenne Muscular Dystrophy Advances In Therapeutics by Jeffrey S. Chamberlain , Thomas A. Rando

    Duchenne Muscular Dystrophy (DMD) is one of the most prevalent genetic disorders of childhood and currently stands as an incurable condition. This authoritative guide provides a clear overview of the latest current and experimental approaches to the treatment of DMD and examines the clinical, genetic, and pathophysiological aspects of the disease in the context of emerging therapeutic modalities. The only available source on the subject, this reference emphasizes the importance of accurate diagnosis, carrier detection, and genetic counseling, and supplies state-of-the-art contributions on pharmacological interventions, regenerative medicine, and gene therapy. EPIDEMIOLOGY. Acute exacerbations are major unmet needs in asthma therapy. Socio-economic costs of acute asthma exacerbations. Seasonal patterns of asthma exacerbations. Aetiology of asthma exacerbations in children. Aetiology of asthma exacerbations in adults. Differentiating asthma exacerbations from poor asthma control. Do frequent exacerbations lead to accelerated long term decline in lung function in asthma? PATHOPHYSIOLOGY. Inflammatory mechanisms of asthma exacerbations. Virus induction of neurogenic inflammation and airway responsiveness. Antiviral immunity and protection against asthma exacerbations. Lessons from RSV bronchiolitis and acute wheezing episodes in infants. Virus induction of steroid resistance. IN-VITRO EXPERIMENTAL MODELS OF ASTHMA EXACERBATIONS. In vitro models of bronchial epithelial cell infection. In vitro models of macrophage infection. IN-VIVO EXPERIMENTAL MODELS OF ASTHMA EXACERBATIONS. Murine models of allergen exposure and virus infection. A murine model of rhinovirus infection. A human experimental model of asthma exacerbation induced by rhinovirus infection. Lessons from human experimental rhinovirus infection in combination with allergen exposure. TREATMENT & PREVENTION OF ASTHMA EXACERBATIONS. Role of established asthma therapies in treating acute asthma exacerbations (adults and children). Role of leukotriene antagonists in the treating acute asthma exacerbations. How good are inhaled steroids alone at preventing asthma exacerbations? (prophylactic and doubling dose). How good are inhaled steroids/LABA in combination at preventing asthma exacerbations? New targets for treatment/prevention of asthma exacerbations. DELIVERY OF CARERole of self-management in preventing asthma exacerbations. Psychosocial factors in severe asthma



    Book Successfully Added To Your Cart